Dianthus Therapeutics Stock Forecast

Stock Price Forecast

The 10 analysts that cover Dianthus Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $121.9, which forecasts a 56.56% increase in the stock price over the next year. The lowest target is $65 and the highest is $200.

Price Target: $121.9 (+56.56%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$65	$121.9	$130	$200
Change	-16.52%	+56.56%	+66.97%	+156.87%

Analyst Ratings

The average analyst rating for Dianthus Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	6	6	5	5	6	7
Buy	5	5	4	4	4	4
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	11	9	9	10	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Laura Chico Wedbush	Wedbush	Buy Maintains $80 → $103	Buy	Maintains	$80 → $103	+32.29%	Mar 12, 2026
Laura Chico Wedbush	Wedbush	Buy Maintains $55 → $80	Buy	Maintains	$55 → $80	+2.75%	Mar 10, 2026
Steven Seedhouse Raymond James	Raymond James	Buy → Strong Buy Upgrades $63 → $123	Buy → Strong Buy	Upgrades	$63 → $123	+57.98%	Mar 10, 2026
Joel Beatty Baird	Baird	Buy Maintains $67 → $132	Buy	Maintains	$67 → $132	+69.54%	Mar 10, 2026
Bill Maughan Clear Street	Clear Street	Strong Buy Maintains $100 → $130	Strong Buy	Maintains	$100 → $130	+66.97%	Mar 10, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.48M

from 2.04M

-27.31%

from 2.04M

Revenue Next Year

2.35M

from 1.48M

58.85%

from 1.48M

EPS This Year

-3.83

from -4.20

EPS Next Year

-4.46

from -3.83

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.48M	6.42M	2.83M	6.24M	2.04M	1.48M	2.35M
Revenue Growth	-	334.76%	-55.96%	120.63%	-67.35%	-27.31%	58.85%
EPS	-3.27	-32.57	-8.45	-2.55	-4.20	-3.83	-4.46
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	16	13

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	4.2M	6.3M
Avg	1.5M	2.4M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	106.3%	325.7%
Avg	-27.3%	58.9%
Low	-	-

EPS Forecast

EPS	2026	2027
High	-3.16	-3.40
Avg	-3.83	-4.46
Low	-4.27	-5.13

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.